2[1]Bergrem H, Danielson BG, Eckardt KU, et al. A case of antierythropoietin antibodies following recombinant human erythropoietin treatment.Erythropoietin : molecular physiology and clinical applications. New York: Marcel Dekker, 1993, 266-275
4[3]MilledgeJS, Cotes PM. Serum erythropoietin in humans at high altitude and its relation to plasma renin. J Appl Physiol, 1985, 59(2) :360-364
5[6]Chandra M, Clemons GK, McVicar MI. Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure.J Pediatr, 1988,113(6):1015- 1021
6[7]Muirhead N, Hodsman AB, Hollomby DJ, et al. The role of aluminium and parathyroid hormone in erythropoietin resistance in haemodialysis patients. Nephrol Dial Transplant, 1991,6(5) :342 - 345
7[8]Maeda Y, Sakaguchi M, Naiki Y, etal. Possible involvement of soluble erythropoietin receptor in resistance to erythropoietin in patients with renal anemia. Am J Nephrol, 2001,21(5) :426
8[9]Carozzi S, Nasini MG, Santoni O, et al. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis. ASAIO J, 1997,43(5): M535 - 538
9[10]Movilli E, Cancarini GC, Zani R, et al. Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients. Nephrol Dial Transplant, 2001,16(1) :111 - 114
10[11]Casedevall N, Nataf J, Viron B, et al. Pure red - cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med, 2002,346(7): 469-478
